TGF-β is also a key driver of EMT, facilitating tumor initiation, invasion and metastasis by regulating multiple signaling pathways, including MAPK/ERK1/2, NF-κB/Snail, JAK/STAT3 and PI3K/AKT signaling [62]. The gene discussed is SNAI1; the disease is neoplasm.